FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915810950> ?p ?o ?g. }

• W2915810950 endingPage "1211.e1" @default.
• W2915810950 startingPage "1204" @default.
• W2915810950 abstract "Background and Aims We aimed to develop risk stratification models for advanced colorectal neoplasia (ACRN) and colorectal cancer (CRC) based on fecal hemoglobin (f-Hb) concentration and clinical risk factors. Methods We reviewed screenees aged ≥50 years who underwent fecal immunochemical test (FIT) and colonoscopy and developed risk-scoring models for ACRN and CRC using logistic regression analysis. Participants were classified into low- (risk lower than that in FIT-negative individuals), intermediate- (risk higher than that in FIT-negative but lower than that in FIT-positive individuals), high- (risk similar to that in FIT-positive individuals), and very-high- (risk higher than that in FIT-positive individuals) risk groups. Results Of 3733 participants, 367 (9.8%) and 70 (1.9%) had ACRN and CRC, respectively. On multivariable analysis, age (ß = .043/y), former smoker (ß = .401), current smoker (ß = .841), diabetes (ß = .097), and square root of f-Hb concentration (ß = .071) were significantly associated with ACRN. In terms of CRC, age (ß = .035/y) and square root of f-Hb concentration (ß = .004) were associated factors. After point assignments based on the regression coefficient, we could classify screenees as low-, intermediate-, high-, and very-high-risk groups. ACRN was identified in 2.9%, 5.3%, 16.2%, and 35.7% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. CRC was identified in .1%, .5%, 3.9%, and 11.1% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. Conclusions The proposed models can effectively stratify the risk for ACRN and CRC and provide accurate information on this risk in individuals who undergo FIT. We aimed to develop risk stratification models for advanced colorectal neoplasia (ACRN) and colorectal cancer (CRC) based on fecal hemoglobin (f-Hb) concentration and clinical risk factors. We reviewed screenees aged ≥50 years who underwent fecal immunochemical test (FIT) and colonoscopy and developed risk-scoring models for ACRN and CRC using logistic regression analysis. Participants were classified into low- (risk lower than that in FIT-negative individuals), intermediate- (risk higher than that in FIT-negative but lower than that in FIT-positive individuals), high- (risk similar to that in FIT-positive individuals), and very-high- (risk higher than that in FIT-positive individuals) risk groups. Of 3733 participants, 367 (9.8%) and 70 (1.9%) had ACRN and CRC, respectively. On multivariable analysis, age (ß = .043/y), former smoker (ß = .401), current smoker (ß = .841), diabetes (ß = .097), and square root of f-Hb concentration (ß = .071) were significantly associated with ACRN. In terms of CRC, age (ß = .035/y) and square root of f-Hb concentration (ß = .004) were associated factors. After point assignments based on the regression coefficient, we could classify screenees as low-, intermediate-, high-, and very-high-risk groups. ACRN was identified in 2.9%, 5.3%, 16.2%, and 35.7% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. CRC was identified in .1%, .5%, 3.9%, and 11.1% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. The proposed models can effectively stratify the risk for ACRN and CRC and provide accurate information on this risk in individuals who undergo FIT." @default.
• W2915810950 created "2019-03-02" @default.
• W2915810950 creator A5005962936 @default.
• W2915810950 creator A5013694438 @default.
• W2915810950 creator A5033450512 @default.
• W2915810950 creator A5042261168 @default.
• W2915810950 creator A5047040022 @default.
• W2915810950 creator A5051699142 @default.
• W2915810950 date "2019-06-01" @default.
• W2915810950 modified "2023-09-27" @default.
• W2915810950 title "Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors" @default.
• W2915810950 cites W1757407923 @default.
• W2915810950 cites W1965422647 @default.
• W2915810950 cites W1980724218 @default.
• W2915810950 cites W2058450271 @default.
• W2915810950 cites W2071941374 @default.
• W2915810950 cites W2084710389 @default.
• W2915810950 cites W2099788846 @default.
• W2915810950 cites W2112383392 @default.
• W2915810950 cites W2117920692 @default.
• W2915810950 cites W2133974148 @default.
• W2915810950 cites W2147549359 @default.
• W2915810950 cites W2158538048 @default.
• W2915810950 cites W2158906537 @default.
• W2915810950 cites W2159239310 @default.
• W2915810950 cites W2165188436 @default.
• W2915810950 cites W2172970386 @default.
• W2915810950 cites W2328176404 @default.
• W2915810950 cites W2518211924 @default.
• W2915810950 cites W2535115137 @default.
• W2915810950 cites W2586554704 @default.
• W2915810950 cites W2617009808 @default.
• W2915810950 cites W2619143830 @default.
• W2915810950 cites W2790420556 @default.
• W2915810950 cites W2799708315 @default.
• W2915810950 doi "https://doi.org/10.1016/j.gie.2019.02.023" @default.
• W2915810950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30817918" @default.
• W2915810950 hasPublicationYear "2019" @default.
• W2915810950 type Work @default.
• W2915810950 sameAs 2915810950 @default.
• W2915810950 citedByCount "13" @default.
• W2915810950 countsByYear W29158109502020 @default.
• W2915810950 countsByYear W29158109502021 @default.
• W2915810950 countsByYear W29158109502022 @default.
• W2915810950 countsByYear W29158109502023 @default.
• W2915810950 crossrefType "journal-article" @default.
• W2915810950 hasAuthorship W2915810950A5005962936 @default.
• W2915810950 hasAuthorship W2915810950A5013694438 @default.
• W2915810950 hasAuthorship W2915810950A5033450512 @default.
• W2915810950 hasAuthorship W2915810950A5042261168 @default.
• W2915810950 hasAuthorship W2915810950A5047040022 @default.
• W2915810950 hasAuthorship W2915810950A5051699142 @default.
• W2915810950 hasConcept C121608353 @default.
• W2915810950 hasConcept C126322002 @default.
• W2915810950 hasConcept C151956035 @default.
• W2915810950 hasConcept C2778435480 @default.
• W2915810950 hasConcept C3020404979 @default.
• W2915810950 hasConcept C526805850 @default.
• W2915810950 hasConcept C71924100 @default.
• W2915810950 hasConcept C90924648 @default.
• W2915810950 hasConceptScore W2915810950C121608353 @default.
• W2915810950 hasConceptScore W2915810950C126322002 @default.
• W2915810950 hasConceptScore W2915810950C151956035 @default.
• W2915810950 hasConceptScore W2915810950C2778435480 @default.
• W2915810950 hasConceptScore W2915810950C3020404979 @default.
• W2915810950 hasConceptScore W2915810950C526805850 @default.
• W2915810950 hasConceptScore W2915810950C71924100 @default.
• W2915810950 hasConceptScore W2915810950C90924648 @default.
• W2915810950 hasIssue "6" @default.
• W2915810950 hasLocation W29158109501 @default.
• W2915810950 hasLocation W29158109502 @default.
• W2915810950 hasOpenAccess W2915810950 @default.
• W2915810950 hasPrimaryLocation W29158109501 @default.
• W2915810950 hasRelatedWork W2086392903 @default.
• W2915810950 hasRelatedWork W2170272972 @default.
• W2915810950 hasRelatedWork W2425239049 @default.
• W2915810950 hasRelatedWork W2758544941 @default.
• W2915810950 hasRelatedWork W2792729164 @default.
• W2915810950 hasRelatedWork W2966059297 @default.
• W2915810950 hasRelatedWork W3004259476 @default.
• W2915810950 hasRelatedWork W3016587774 @default.
• W2915810950 hasRelatedWork W3087237052 @default.
• W2915810950 hasRelatedWork W4244458355 @default.
• W2915810950 hasVolume "89" @default.
• W2915810950 isParatext "false" @default.
• W2915810950 isRetracted "false" @default.
• W2915810950 magId "2915810950" @default.
• W2915810950 workType "article" @default.